209
Views
1
CrossRef citations to date
0
Altmetric
Review

What Does Next-Generation Sequencing Mean for Prenatal Diagnosis?

, &
Pages 499-508 | Published online: 06 May 2014

References

  • Chiu RW , CantorCR , LoYM. Non-invasive prenatal diagnosis by single molecule counting technologies.Trends Genet.25 ( 7 ), 324 – 331 ( 2009 ).
  • Bianchi DW . Prenatal diagnostics: fetal genes in mother's blood.Nature487 ( 7407 ), 304 – 305 ( 2012 ).
  • Allison M . Genomic testing reaches into the womb.Nat. Biotechnol.31 ( 7 ), 595 – 601 ( 2013 ).
  • Agarwal A , SayresLC , ChoMK , Cook-DeeganR , ChandrasekharanS. Commercial landscape of noninvasive prenatal testing in the United States.Prenat. Diagn.33 ( 6 ), 521 – 531 ( 2013 ).
  • Lo YM , CorbettaN , ChamberlainPFet al. Presence of fetal DNA in maternal plasma and serum. Lancet 350 , 485 – 487 ( 1997 ).
  • Lo YM , ZhangJ , LeungTN , LauTK , ChangAM , HjelmNM. Rapid clearance of fetal DNA from maternal plasma.Am. J. Hum. Genet.64 ( 1 ), 218 – 224 ( 1999 ).
  • Kollmann M , HaeuslerM , HaasJ , CsapoB , LangU , KlaritschP. Procedure-related complications after genetic amniocentesis and chorionic villus sampling.Ultraschall. Med.34 ( 4 ), 345 – 348 ( 2013 ).
  • Tabor A , PhilipJ , MadsenM , BangJ , ObelEB , N⊘rgaard-PedersenB. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.Lancet1 , 1287 – 1293 ( 1986 ).
  • Nicolaides KH . Screening for fetal aneuploidies at 11 to 13 weeks.Prenat. Diagn.31 ( 1 ), 7 – 15 ( 2011 ).
  • Garrouste C , LeJ , MaurinE. The choice of detecting Down syndrome: does money matter?Health Econ.20 ( 9 ), 1073 – 1089 ( 2011 ).
  • Izquierdo LA , BerkshireS. Access, quality and costs of prenatal diagnosis.Bol. Asoc. Med. P. R.102 ( 4 ), 25 – 29(2010) .
  • Morris JK , AlbermanE. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.BMJ339 , b3794 ( 2009 ).
  • Wapner RJ , MartinCL , LevyBet al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med. 367 ( 23 ), 2175 – 2184 ( 2012 ).
  • American College of Obstetricians and Gynecologists . ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.Obstet. Gynecol.110 ( 6 ), 1459 – 1467 ( 2007 ).
  • Lapaire O , HolzgreveW , OosterwijkJC , BrinkhausR , BianchiDW. Georg Schmorl on trophoblasts in the maternal circulation.Placenta28 ( 1 ), 1 – 5 ( 2007 ).
  • Hahn S , JacksonLG , KollaV , MahyuddinAP , ChoolaniM. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies.Expert Rev. Mol. Diagn.9 ( 6 ), 613 – 621 ( 2009 ).
  • Bianchi DW , SimpsonJL , JacksonLGet al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat. Diagn. 22 ( 7 ), 609 – 615 ( 2002 ).
  • Hatt L , BrinchM , SinghR. Characterization of fetal cells from the maternal circulation by microarray gene expression analysis – could the extravillous trophoblasts be a target for future cell-based non-invasive prenatal diagnosis?Fetal Diagn. Ther.   doi:10.1159/000356073 ( 2013 )  (Epub ahead of print) .
  • Zimmermann B , El-SheikhahA , NicolaidesK , HolzgreveW , HahnS. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma.Clin. Chem.51 ( 9 ), 1598 – 1604 ( 2005 ).
  • Lo YM , TeinMS , LauTKet al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62 , 768 – 775 ( 1998 ).
  • Van der Schoot CE , HahnS , ChittyLS. Non-invasive prenatal diagnosis and determination of fetal Rh status.Semin. Fetal Neonatal Med.13 ( 2 ), 63 – 68 ( 2008 ).
  • Ehrich M , DeciuC , ZwiefelhoferTet al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am. J. Obstet. Gynecol. 204 , 205.e1 – e11 ( 2011 ).
  • Chiu R , AkolekarR , ZhengYWLet al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342 , c7401 ( 2011 ).
  • Palomaki GE , KlozaEM , Lambert-MesserlianGMet al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet. Med. 13 , 913 – 920 ( 2011 ).
  • Bianchi DW , PlattLD , GoldbergJD , AbuhamadAZ , SehnertAJ , RavaRP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.Obstet. Gynecol.119 , 1 – 13 ( 2012 ).
  • Sparks AB , StrubleCA , WangET , SongK , OliphantA. Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.Am. J. Obstet. Gynecol.206 , 322.e1 – 5 ( 2012 ).
  • Ashoor G , SyngelakiA , WagnerM , BirdirC , NicolaidesKH. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.Am. J. Obstet. Gynecol.206 ( 4 ), 322.e1 – 5 ( 2012 ).
  • Norton ME , BrarH , WeissJet al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 207 ( 2 ), 137.e1 – 8 ( 2012 ).
  • Zimmermann B , HillM , GemelosGet al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat. Diagn. 32 ( 13 ), 1233 – 1241 ( 2012 ).
  • Nicolaides KH , SyngelakiA , GilM , AtanasovaV , MarkovaD. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.Prenat. Diagn.33 ( 6 ), 575 – 579 ( 2013 ).
  • Samango-Sprouse C , BanjevicM , RyanAet al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat. Diagn. 33 ( 7 ), 643 – 649 ( 2013 ).
  • Metzker ML . Sequencing technologies – the next generation.Nat. Rev. Genet.11 ( 1 ), 31 – 46 ( 2010 ).
  • Rizzo JM , BuckMJ. Key principles and clinical applications of ‘next-generation’ DNA sequencing.Cancer Prev. Res.5 ( 7 ), 887 – 900 ( 2012 ).
  • Chiu RWK , ChanKCA , GaoYet al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl Acad. Sci. USA 105 ( 51 ), 20458 – 20463 ( 2008 ).  
  • Fan HC , BlumenfeldYJ , ChitkaraU , HudginsL , QuakeSR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood.Proc. Natl Acad. Sci. USA105 , 16266 – 16271 ( 2008 ).
  • Boon EM , FaasBH. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies.Prenat. Diagn.33 ( 6 ), 563 – 568 ( 2013 ).
  • Ashoor G , SyngelakiA , WangEet al. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet. Gynecol. 41 ( 1 ), 21 – 25 ( 2013 ).
  • Norton ME , BrarH , WeissJet al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 207 , 1 – 8 ( 2012 ).
  • Sparks AB , WangET , StrubleCAet al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat. Diagn. 32 ( 1 ), 3 – 9 ( 2012 ).
  • Liao GJW , ChanKCA , JiangPet al. Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. PLoS ONE 7 ( 5 ), e38154 ( 2012 ).
  • Benn P , CuckleH , PergamentE. Non-invasive prenatal testing for aneuploidy: current status and future prospects.Ultrasound Obstet. Gynecol.42 ( 1 ), 15 – 33 ( 2013 ).
  • Nicolaides KH , SyngelakiA , GilMDM , QuezadaMS , ZinevichY. Prenatal detection of fetal triploidy from cell-free DNA testing in maternal blood.Fetal Diagn. Ther. doi:10.1159/000355655 ( 2013 ) (Epub ahead of print) .
  • Benn P , BorellA , ChiuRet al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 33 ( 7 ), 622 – 629 ( 2013 ).
  • Devers P , CronisterA , OrmondK , FacioF , BrasingtonC , FlodmanP. Noninvasive prenatal testing/noninvasive prenatal diagnosis:the position of the national society of genetic counselors.J. Genet. Couns.22 ( 3 ), 291 – 295 ( 2013 ).
  • American College of Obstetricians and Gynecologists . Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545.Obstet. Gynecol.120 , 1532 – 1534 ( 2012 ).
  • Palomaki GE , DeciuC , KlozaEMet al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet. Med. 14 ( 3 ), 296 – 305 ( 2012 ).
  • Dohm JC , LottazC , BorodinaT , HimmelbauerH. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing.Nucleic Acids Res.36 ( 16 ), e105 ( 2008 ).
  • Wright CF , WeiY , HigginsJPT , SagooGS. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.BMC Res. Notes5 , 476 ( 2012 ).
  • Mazloom AR , DžakulaŽ , OethPet al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat. Diagn. 33 ( 6 ), 591 – 597 ( 2013 ).
  • Song Y , LiuC , QiH , ZhangY , BianX , LiuJ. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population.Prenat. Diagn.33 ( 7 ), 700 – 706 ( 2013 ).
  • Guex N , IseliC , SyngelakiAet al. A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat. Diagn. 33 ( 7 ), 707 – 710 ( 2013 ).
  • Spencer K , LiaoAW , SkentouH , CiceroS , NicolaidesKH. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10–14 weeks of gestation.Prenat. Diagn.20 ( 6 ), 495 – 499 ( 2000 ).
  • Canick JA , PalomakiGE , KlozaEM , Lambert-MesserlianGM , HaddowJE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.Prenat. Diagn.33 ( 7 ), 667 – 674 ( 2013 ).
  • Forabosco A , PercesepeA , SantucciS. Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses.Eur. J. Hum. Genet.17 ( 7 ), 897 – 903 ( 2009 ).
  • Lau TK , JiangF , ChanMK , ZhangH , LoPSS , WangW. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.J. Matern. Fetal Neonatal Med.26 ( 4 ), 434 – 437 ( 2013 ).
  • Gil MM , QuezadaMS , BregantB , SyngelakiA , NicolaidesKH. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies.Fetal Diagn. Ther. doi:10.1159/000356495 ( 2013 ) (Epub ahead of print) .
  • Canick JA , KlozaEM , Lambert-MesserlianGMet al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat. Diagn. 32 ( 8 ), 730 – 734 ( 2012 ).
  • Fairbrother G , JohnsonS , MusciTJ , SongK. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.Prenat. Diagn.33 ( 6 ), 580 – 583 ( 2013 ).
  • Gil MM , QuezadaMS , BregantB , FerraroM , NicolaidesKH. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.Ultrasound Obstet. Gynecol.42 ( 1 ), 34 – 40 ( 2013 ).
  • Nicolaides KH , WrightD , PoonLC , SyngelakiA , GilMM. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.Ultrasound Obstet. Gynecol.42 ( 1 ), 41 – 50 ( 2013 ).
  • Swanson A , SehnertAJ , BhattS. Non-invasive prenatal testing: technologies, clinical assays and implementation strategies for women's healthcare practitioners.Curr. Genet. Med. Rep.1 ( 2 ), 113 – 121 ( 2013 ).
  • Bianchi DW , Wilkins-HaugL. Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?Clin. Chem.60 ( 1 ), 78 – 87 ( 2014 ).
  • Taylor JB , ChockVY , HudginsL. NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability.J. Genet. Couns.23 ( 1 ), 72 – 78 ( 2014 ).
  • Dan S , WangW , RenJet al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat. Diagn. 32 ( 13 ), 1225 – 1232 ( 2012 ).
  • Futch T , SpinosaJ , BhattS , de FeoE , RavaRP , SehnertAJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples.Prenat. Diagn.33 ( 6 ), 569 – 574 ( 2013 ).
  • Musci TJ , FairbrotherG , BateyA , BruursemaJ , StrubleC , SongK. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice.Prenat. Diagn.33 ( 5 ), 424 – 428 ( 2013 ).
  • Manegold-Brauer G , KangBellin A , HahnSet al. A new era in prenatal care: non-invasive prenatal testing (NIPT) in Switzerland. Swiss Med. Wkly 143 , w13915 ( 2013 ).
  • Chetty S , GarabedianMJ , NortonME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.Prenat. Diagn.33 ( 6 ), 542 – 546 ( 2013 ).
  • Ong FS , GrodyWW , DeignanJL. Privacy and data management in the era of massively parallel next-generation sequencing.Expert Rev. Mol. Diagn.11 ( 5 ), 457 – 459 ( 2011 ).
  • De Jong A , DondorpWJ , KrumeichA , BoonekampJ , van LithJM , de WertGM. The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users.J. Community Genet.4 ( 1 ), 125 – 135 ( 2013 ).
  • Hahn S , HoesliI , LapaireO. Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges.Expert Opin. Med. Diagn.6 ( 6 ), 517 – 528 ( 2012 ).
  • Skirton H , GoldsmithL , JacksonL , LewisC , ChittyL. Offering prenatal diagnostic tests: European guidelines for clinical practice guidelines.Eur. J. Hum. Genet. doi:10.1038/ejhg.2013.205 ( 2013 ) ( Epub ahead of print ).  
  • Bianchi DW . At-home fetal DNA gender testing: caveat emptor.Obstet. Gynecol.107 ( 2 Pt 1 ), 216 – 218 ( 2006 ).
  • Kelly SE , FarrimondHR. Non-invasive prenatal genetic testing: a study of public attitudes.Public Health Genomics15 ( 2 ), 73 – 81 ( 2012 ).
  • Hui L , SlonimDK , WickHC , JohnsonKL , KoideK , BianchiDW. Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21.Hum. Genet.131 ( 11 ), 1751 – 1759 ( 2012 ).
  • Slonim DK , KoideK , JohnsonKLet al. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc. Natl Acad. Sci. USA 106 ( 23 ), 9425 – 9429 ( 2009 ).
  • Guedj F , BianchiDW. Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.Prenat. Diagn.33 ( 6 ), 614 – 618 ( 2013 ).
  • Incerti M , HorowitzK , RobersonRet al. Prenatal treatment prevents learning deficit in Down syndrome model. PLoS ONE 7 ( 11 ), e50724 ( 2012 ).
  • Hahn S , RusterholzC , HösliI , LapaireO. Cell-free nucleic acids as potential markers for preeclampsia.Placenta32 ( Suppl. ), S17 – S20 ( 2011 ).
  • Lo YM , ChiuRW. Noninvasive approaches to prenatal diagnosis of hemoglobinopathies using fetal DNA in maternal plasma.Hematol. Oncol. Clin. North Am.24 ( 6 ), 1179 – 1186 ( 2010 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.